Cytokinetics has released comprehensive results from its late-stage clinical trial demonstrating significant efficacy for a novel therapy treating non-obstructive hypertrophic cardiomyopathy. The findings were presented at the European Society of Cardiology congress and published in a leading medical journal.

A significant advancement in the treatment of muscle-invasive bladder cancer (MIBC) has been published in the New England Journal of Medicine, highlighting the superior efficacy of enfortumab vedotin and pembrolizumab combination therapy over chemotherapy.

A 68-year-old woman experienced a blue-gray discoloration in her hands and feet just weeks after starting a common medication, according to a medical report published in the New England Journal of Medicine.